|Title:||ZHAW Waedenswil : a new approach in the fight against cancer|
|Authors :||Rimann, Markus|
|Published in :||Chimia|
|Publisher / Ed. Institution :||Schweizerische Chemische Gesellschaft|
|License (according to publishing contract) :||Licence according to publishing contract|
|Type of review:||Peer review (publication)|
|Subjects :||Alginates; Antineoplastic Agents; Biological Assay; Biomedical Research; Biomedical Technology; Glucuronic Acid; Hexuronic Acids; Humans; Lung Neoplasms; Mesothelioma; Tumor Cells, Cultured; Cell Culture Techniques|
|Subject (DDC) :||616: Internal medicine and diseases|
|Abstract:||A happy coincidence brought Dr Markus Rimann from ZHAW Waedenswil together with Dr Andreas Meyer from the start-up FGen and PD Dr Emanuela Felley-Bosco, Molecular Oncologist at Zurich University Hospital, to develop a technology platform for the manufacture and high throughput analysis of single mesothelioma spheroids. Armin Picenoni, former student in Chemistry for the Life Sciences at ZHAW, confirmed everything in writing his Master Thesis on this Innosuisse project.|
|Departement:||Life Sciences and Facility Management|
|Organisational Unit:||Institute of Chemistry and Biotechnology (ICBT)|
|Publication type:||Article in scientific journal|
|Appears in Collections:||Publikationen Life Sciences und Facility Management|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.